Form 8-K - Current report:
SEC Accession No. 0000950123-09-050478
Filing Date
2009-10-15
Accepted
2009-10-15 06:06:30
Documents
2
Period of Report
2009-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y02395e8vk.htm 8-K 8862
2 EX-99.1 y02395exv99w1.htm EX-99.1 10816
  Complete submission text file 0000950123-09-050478.txt   21419
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 091120320
SIC: 2836 Biological Products, (No Diagnostic Substances)